Centessa Pharmaceuticals plc (CNTA) Misses Q2 EPS by 1c
Tweet
Share
E-mail
Get Alerts CNTA Hot Sheet
Join SI Premium – FREE
Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q2 EPS of ($0.40), $0.01 worse than the analyst estimate of ($0.39).
For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Burckhardt Compression (BCHN:SW) PT Lowered to CHF620 at Berenberg
- Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance
- Goldman Sachs Starts United Therapeutics Corp. (UTHR) at Sell
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
